What is the definition of neuroendocrine carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Neuroendocrine Carcinoma

Neuroendocrine carcinoma (NEC) is a rare, aggressive form of cancer that originates from neuroendocrine cells throughout the body, characterized by high proliferation rates, poor differentiation, and worse prognosis compared to well-differentiated neuroendocrine tumors. 1

Classification of Neuroendocrine Neoplasms

Neuroendocrine neoplasms (NENs) are classified based on differentiation and grading:

  1. Differentiation:

    • Well-differentiated neuroendocrine tumors (NETs)
    • Poorly differentiated neuroendocrine carcinomas (NECs)
  2. Grading:

    • Grade 1 (G1): Well-differentiated, low-grade
    • Grade 2 (G2): Well-differentiated, intermediate-grade
    • Grade 3 (G3): Poorly differentiated, high-grade 1

Key Diagnostic Features of Neuroendocrine Carcinoma

NECs are specifically characterized by:

  • Poorly differentiated histology with minimal resemblance to tissue of origin
  • High proliferation rate: typically >20 mitoses per 10 high-power fields (HPF)
  • Ki-67 proliferation index typically exceeding 20%
  • Aggressive biological behavior
  • Worse prognosis compared to lower grades 1

Morphology and Locations

NECs can arise in various locations:

  • Respiratory tract (lungs and bronchi - 25% of all NETs)
  • Gastrointestinal tract
  • Pancreas
  • Thymus
  • Other sites 1

Distinction from Well-Differentiated NETs

It's important to understand that NECs differ from well-differentiated NETs:

  • NECs represent only 10-20% of all neuroendocrine neoplasms 2
  • NECs are poorly differentiated and high-grade by definition
  • NECs have more aggressive behavior and worse outcomes
  • NECs typically require different treatment approaches (platinum-based chemotherapy) compared to well-differentiated NETs 1

Important Terminology Considerations

  • The term "carcinoid" should be limited to well-differentiated midgut NETs that secrete serotonin, not used for all neuroendocrine neoplasms 1
  • NECs should be distinguished from well-differentiated G3 NETs, as they have different prognosis and treatment approaches despite both having high proliferation rates 1

Clinical Implications

Accurate classification of NECs is essential for:

  • Appropriate treatment planning
  • Prognostication
  • Determining eligibility for specific treatment protocols
  • Establishing appropriate follow-up schedules due to higher recurrence risk 1

Misclassification can lead to inappropriate treatment selection and underestimation of disease aggressiveness, potentially compromising patient outcomes.

References

Guideline

Neuroendocrine Carcinoma Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.